Ekso Bionics Holdings, Inc. acquired Human Motion and Control Business Unit of Parker Hannifin Corporation for $10 million on December 5, 2022. Out of $10 million, $5 million will be paid at closing and for the remaining $5 million, subordinated, unsecured zero coupon note will be payable quarterly over four years. The acquisition also includes Indego lower limb exoskeleton line of products, planned development of robotic assisted orthotic and prosthetic devices. Post acquisition, Scott Davis will serve as Chief Executive Officer and Steven Sherman will continue to serve as Chairman of the Board and will begin serving as Executive Chair of Esko. Wilson Sonsini Goodrich & Rosati, P.C. acted as legal advisor to Ekso Bionics Holdings, Inc. (NasdaqCM:EKSO).

Ekso Bionics Holdings, Inc. completed the acquisition of Human Motion and Control Business Unit of Parker Hannifin Corporation on December 5, 2022. Patrick Leddy of Jones Day acted as legal advisor to Parker-Hannifin Corporation in the transaction.